Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 3
2006 5
2007 6
2008 11
2009 22
2010 18
2011 26
2012 25
2013 31
2014 27
2015 29
2016 29
2017 32
2018 26
2019 34
2020 23
2021 8
Text availability
Article attribute
Article type
Publication date

Search Results

297 results
Results by year
Filters applied: . Clear all
Page 1
Myocardial Infarct Size by CMR in Clinical Cardioprotection Studies: Insights From Randomized Controlled Trials.
Bulluck H, Hammond-Haley M, Weinmann S, Martinez-Macias R, Hausenloy DJ. Bulluck H, et al. JACC Cardiovasc Imaging. 2017 Mar;10(3):230-240. doi: 10.1016/j.jcmg.2017.01.008. JACC Cardiovasc Imaging. 2017. PMID: 28279370 Free PMC article. Review.
OBJECTIVES: The aim of this study was to review randomized controlled trials (RCTs) using cardiac magnetic resonance (CMR) to assess myocardial infarct (MI) size in reperfused patients with ST-segment elevation myocardial infarction (STEM …
OBJECTIVES: The aim of this study was to review randomized controlled trials (RCTs) using cardiac magnetic resonance (CMR) to assess …
Validation of contemporary electrocardiographic indices of area at risk and infarct size in acute ST elevation myocardial infarction (STEMI).
Du YT, Pasupathy S, Air T, Neil C, Beltrame JF. Du YT, et al. Int J Cardiol. 2020 Mar 15;303:1-7. doi: 10.1016/j.ijcard.2019.10.041. Epub 2019 Nov 13. Int J Cardiol. 2020. PMID: 31759688 Clinical Trial.
BACKGROUND: Electrocardiographic (ECG) methods to assess area at risk (AAR) and infarct size (IS) in patients with ST-elevation myocardial infarction (STEMI) have been previously established but not validated against contemporary benchmark Cardiac Magn …
BACKGROUND: Electrocardiographic (ECG) methods to assess area at risk (AAR) and infarct size (IS) in patients with ST-elevatio …
Culprit vessel-related myocardial mechanics and prognostic implications following acute myocardial infarction.
Backhaus SJ, Kowallick JT, Stiermaier T, Lange T, Koschalka A, Navarra JL, Lotz J, Kutty S, Bigalke B, Gutberlet M, Feistritzer HJ, Hasenfuß G, Thiele H, Schuster A, Eitel I. Backhaus SJ, et al. Clin Res Cardiol. 2020 Mar;109(3):339-349. doi: 10.1007/s00392-019-01514-x. Epub 2019 Jul 5. Clin Res Cardiol. 2020. PMID: 31278521 Clinical Trial.
BACKGROUND: Prognosis in acute myocardial infarction (AMI) depends on the amount of infarct-related artery (IRA)-subtended myocardium and associated damage but has not been described in great detail. ...In AUC analyses, epsilon(s) (LAD, RCA) and …
BACKGROUND: Prognosis in acute myocardial infarction (AMI) depends on the amount of infarct-related artery (IRA) …
Impact of infarct location and size on clinical outcome after ST-elevation myocardial infarction treated by primary percutaneous coronary intervention.
Reindl M, Holzknecht M, Tiller C, Lechner I, Schiestl M, Simma F, Pamminger M, Henninger B, Mayr A, Klug G, Bauer A, Metzler B, Reinstadler SJ. Reindl M, et al. Int J Cardiol. 2020 Feb 15;301:14-20. doi: 10.1016/j.ijcard.2019.11.123. Epub 2019 Nov 17. Int J Cardiol. 2020. PMID: 31761400
BACKGROUND: For patients suffering from acute ST-elevation myocardial infarction (STEMI), it is controversial whether infarct location predicts worse clinical outcome independently of infarct size. ...CONCLUSIONS: The higher rate of mediu …
BACKGROUND: For patients suffering from acute ST-elevation myocardial infarction (STEMI), it is controversial whether …
G-CSF for Extensive STEMI.
Achilli F, Pontone G, Bassetti B, Squadroni L, Campodonico J, Corrada E, Facchini C, Mircoli L, Esposito G, Scarpa D, Pidello S, Righetti S, Di Gennaro F, Guglielmo M, Muscogiuri G, Baggiano A, Limido A, Lenatti L, Di Tano G, Malafronte C, Soffici F, Ceseri M, Maggiolini S, Colombo GI, Pompilio G; STEM-AMI OUTCOME CMR Sub-Study Investigators. Achilli F, et al. Circ Res. 2019 Jul 19;125(3):295-306. doi: 10.1161/CIRCRESAHA.118.314617. Epub 2019 May 29. Circ Res. 2019. PMID: 31138020 Free article. Clinical Trial.
OBJECTIVE: The STEM-AMI OUTCOME CMR (Stem Cells Mobilization in Acute Myocardial Infarction Outcome Cardiac Magnetic Resonance) Substudy was adequately powered to evaluate, in a population showing LV ejection fraction 45% after percutaneous coronary in …
OBJECTIVE: The STEM-AMI OUTCOME CMR (Stem Cells Mobilization in Acute Myocardial Infarction Outcome Cardiac Magn …
Hyper-acute cardiovascular magnetic resonance T1 mapping predicts infarct characteristics in patients with ST elevation myocardial infarction.
Alkhalil M, Borlotti A, De Maria GL, Wolfrum M, Dawkins S, Fahrni G, Gaughran L; Oxford Acute Myocardial Infarction (OxAMI) Study, Langrish JP, Lucking A, Ferreira VM, Kharbanda RK, Banning AP, Dall'Armellina E, Channon KM, Choudhury RP. Alkhalil M, et al. J Cardiovasc Magn Reson. 2020 Jan 9;22(1):3. doi: 10.1186/s12968-019-0593-9. J Cardiovasc Magn Reson. 2020. PMID: 31915031 Free PMC article.
BACKGROUND: Myocardial recovery after primary percutaneous coronary intervention in acute myocardial infarction is variable and the extent and severity of injury are difficult to predict. ...The characteristics of myocardial injury within 3 h wa …
BACKGROUND: Myocardial recovery after primary percutaneous coronary intervention in acute myocardial infarction
Impact of Morphine Treatment on Infarct Size and Reperfusion Injury in Acute Reperfused ST-Elevation Myocardial Infarction.
Eitel I, Wang J, Stiermaier T, Fuernau G, Feistritzer HJ, Joost A, Jobs A, Meusel M, Blodau C, Desch S, de Waha-Thiele S, Langer H, Thiele H. Eitel I, et al. J Clin Med. 2020 Mar 9;9(3):735. doi: 10.3390/jcm9030735. J Clin Med. 2020. PMID: 32182847 Free PMC article.
Current evidence regarding the effect of intravenous morphine administration on reperfusion injury and/or cardioprotection in patients with myocardial infarction is conflicting. The aim of this study was to evaluate the impact of morphine administration, on infar
Current evidence regarding the effect of intravenous morphine administration on reperfusion injury and/or cardioprotection in patients with …
Biomarker assessment for early infarct size estimation in ST-elevation myocardial infarction.
Tiller C, Reindl M, Holzknecht M, Klapfer M, Beck A, Henninger B, Mayr A, Klug G, Reinstadler SJ, Metzler B. Tiller C, et al. Eur J Intern Med. 2019 Jun;64:57-62. doi: 10.1016/j.ejim.2019.03.001. Epub 2019 Mar 14. Eur J Intern Med. 2019. PMID: 30878297 Free article.
BACKGROUND: High-sensitivity cardiac troponin T (hs-cTnT) represents the biomarker of choice for infarct size (IS) estimation in patients with acute ST-elevation myocardial infarction (STEMI). ...The following biomarkers were assessed on admissi …
BACKGROUND: High-sensitivity cardiac troponin T (hs-cTnT) represents the biomarker of choice for infarct size (IS) estimation …
Efficacy of IntraCoronary Erythropoietin Delivery BEfore Reperfusion-Gauging Infarct Size in Patients with Acute ST-segment Elevation Myocardial Infarction (ICEBERG).
Seo WW, Suh JW, Oh IY, Yoon CH, Cho YS, Youn TJ, Chae IH, Choi DJ. Seo WW, et al. Int Heart J. 2019 Mar 20;60(2):255-263. doi: 10.1536/ihj.18-035. Epub 2019 Feb 22. Int Heart J. 2019. PMID: 30799375 Free article. Clinical Trial.
The primary endpoint was infarct size estimated by serial cardiac enzyme levels after procedure. ...Composite cardiovascular outcomes did not differ between the two groups.In conclusion, administration of intracoronary darbepoetin-alpha before reperfusion did not re …
The primary endpoint was infarct size estimated by serial cardiac enzyme levels after procedure. ...Composite cardiovascular o …
Microvascular leakage in acute myocardial infarction: characterization by histology, biochemistry, and magnetic resonance imaging.
Gao XM, Wu QZ, Kiriazis H, Su Y, Han LP, Pearson JT, Taylor AJ, Du XJ. Gao XM, et al. Am J Physiol Heart Circ Physiol. 2017 May 1;312(5):H1068-H1075. doi: 10.1152/ajpheart.00073.2017. Epub 2017 Mar 24. Am J Physiol Heart Circ Physiol. 2017. PMID: 28341632 Free article.

The size of MVL, infarction, and MVO in the heart was quantified histologically. ...Within the risk zone, the area of MVL (75 2%) was greater than that of infarct (47 4%, P < 0.01) or MVO (36 4%, P < 0.01). Contour analysis of paired CMR-LGE by

The size of MVL, infarction, and MVO in the heart was quantified histologically. ...Within the risk zone, the area of MVL (75 …
297 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page